Alnylam Pharmaceuticals (ALNY) Operating Leases (2019 - 2026)
Alnylam Pharmaceuticals (ALNY) posted Operating Leases of $210.5 million for Q2 2026, down 6.2% from $224.45 million a year earlier and down 3.5% from the prior quarter.
Alnylam Pharmaceuticals (ALNY) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Alnylam Pharmaceuticals' Operating Leases came in at $225.09 million, down 1.9% from FY2024.
- Annual Operating Leases has declined for five consecutive years, with a five-year compound annual growth rate of -5.1% (FY2020 to FY2025).
- In prior years, Alnylam Pharmaceuticals' Operating Leases was $229.54 million in FY2024 (-5.6%), $243.1 million in FY2023 (-7.0%), $261.34 million in FY2022 (-7.1%) and $281.35 million in FY2021 (-4.0%).
- The Q2 2026 figure stands as the lowest quarterly Operating Leases in data going back to Q1 2019.
- On a year-over-year basis, Operating Leases has declined in each of the last 20 quarters, with an average decline of 4.8% over the last eight quarters.
- The year-over-year decline in Operating Leases has ranged between 1.9% (Q4 2025) and 8.3% (Q1 2024) over the last five years.
- According to Business Quant data, Operating Leases for the three prior quarters was $218.03 million (Q1 2026), $225.09 million (Q4 2025) and $223.42 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | Alnylam Pharmaceuticals | 34.23 Bn | 22.28 Bn | 992.69 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 210.50 Mn |
| Mar 31, 2026 | 218.03 Mn |
| Dec 31, 2025 | 225.09 Mn |
| Sep 30, 2025 | 223.42 Mn |
| Jun 30, 2025 | 224.45 Mn |
| Mar 31, 2025 | 230.06 Mn |
| Dec 31, 2024 | 229.54 Mn |
| Sep 30, 2024 | 236.03 Mn |
| Jun 30, 2024 | 239.35 Mn |
| Mar 31, 2024 | 237.83 Mn |
| Dec 31, 2023 | 243.10 Mn |
| Sep 30, 2023 | 247.71 Mn |
| Jun 30, 2023 | 253.42 Mn |
| Mar 31, 2023 | 259.40 Mn |
| Dec 31, 2022 | 261.34 Mn |
| Sep 30, 2022 | 266.32 Mn |
| Jun 30, 2022 | 272.02 Mn |
| Mar 31, 2022 | 277.39 Mn |
| Dec 31, 2021 | 281.35 Mn |
| Sep 30, 2021 | 286.03 Mn |
Alnylam Pharmaceuticals Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=ALNY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();